메뉴 건너뛰기




Volumn 319, Issue 1-2, 2006, Pages 71-81

Novel design of osmotic chitosan capsules characterized by asymmetric membrane structure for in situ formation of delivery orifice

Author keywords

Asymmetric membrane; Chitosan; In situ orifice formation; Osmotic; Poorly soluble drugs

Indexed keywords

CHITOSAN; CHLOROPHYLL; DODECYL SULFATE SODIUM; FELODIPINE; HYDROXYPROPYLMETHYLCELLULOSE PHTHALATE; NIFEDIPINE; TRIPOLYPHOSPHATE;

EID: 33745913907     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2006.03.041     Document Type: Article
Times cited : (12)

References (18)
  • 1
    • 0030114263 scopus 로고    scopus 로고
    • Effect of molecular weight of chitosan with the same degree of deacetylation on the thermal, mechanical and permeability properties of the prepared membrane
    • Chen R.H., and Hwa H.D. Effect of molecular weight of chitosan with the same degree of deacetylation on the thermal, mechanical and permeability properties of the prepared membrane. Carbohydr. Polym. 29 (1996) 353-358
    • (1996) Carbohydr. Polym. , vol.29 , pp. 353-358
    • Chen, R.H.1    Hwa, H.D.2
  • 3
    • 33745888169 scopus 로고    scopus 로고
    • Daly, M.M., Keown, R.W., Knorr, D.W., 1989. Chitosan alginate capsules, United States Patent Number 4,808,707.
  • 6
    • 0035401108 scopus 로고    scopus 로고
    • Characterization of METHOCEL cellulose ethers by aqueous SEC with multiple detectors
    • Keary C.M. Characterization of METHOCEL cellulose ethers by aqueous SEC with multiple detectors. Carbohydr. Polym. 45 (2001) 293-303
    • (2001) Carbohydr. Polym. , vol.45 , pp. 293-303
    • Keary, C.M.1
  • 7
    • 33745919611 scopus 로고    scopus 로고
    • Lim, F., 1982 Encapsulation of biological material, United States Patent No. 4,352,883.
  • 8
    • 0037437074 scopus 로고    scopus 로고
    • Investigations on the drug releasing mechanism from an asymmetric membrane-coated capsule with an in situ formed delivery orifice
    • Lin Y.K., and Ho H.O. Investigations on the drug releasing mechanism from an asymmetric membrane-coated capsule with an in situ formed delivery orifice. J. Control. Release 89 (2003) 57-69
    • (2003) J. Control. Release , vol.89 , pp. 57-69
    • Lin, Y.K.1    Ho, H.O.2
  • 9
    • 0031375574 scopus 로고    scopus 로고
    • Chitosan tablets for controlled release of theophylline: Effect of polymer - drug wet or dry blending and anionic-cationic interpolymer complex
    • Mi F.L., Her N.L., Kuan C.Y., Wong T.B., and Shyu S.S. Chitosan tablets for controlled release of theophylline: Effect of polymer - drug wet or dry blending and anionic-cationic interpolymer complex. J. Appl. Polym. Sci. 66 (1997) 2495-2505
    • (1997) J. Appl. Polym. Sci. , vol.66 , pp. 2495-2505
    • Mi, F.L.1    Her, N.L.2    Kuan, C.Y.3    Wong, T.B.4    Shyu, S.S.5
  • 11
    • 33745907910 scopus 로고    scopus 로고
    • Rha, C., Rodriguez-Sanchez, D., 1988. Process for encapsulation and encapsulated active material system. United State Patent No. 4,744,933.
  • 12
    • 0026670086 scopus 로고
    • Immobilization of yeast cells with cross-linked chitosan beads
    • Shinonaga M.A., Kawamura Y., and Yamane T. Immobilization of yeast cells with cross-linked chitosan beads. J. Ferment. Bioeng. 74 (1992) 90-94
    • (1992) J. Ferment. Bioeng. , vol.74 , pp. 90-94
    • Shinonaga, M.A.1    Kawamura, Y.2    Yamane, T.3
  • 13
    • 1842843556 scopus 로고    scopus 로고
    • The influence of multivalent phosphate structure on the properties of ionically cross-linked chitosan films for controlled drug release
    • Shu X.Z., and Zhu K.J. The influence of multivalent phosphate structure on the properties of ionically cross-linked chitosan films for controlled drug release. Eur. J. Pharm. Biopharm. 54 (2002) 235-243
    • (2002) Eur. J. Pharm. Biopharm. , vol.54 , pp. 235-243
    • Shu, X.Z.1    Zhu, K.J.2
  • 14
    • 33745926603 scopus 로고    scopus 로고
    • Suzuki, T., Hashiudo, K., Matsumoto, T., Higashide, T., 1994. Large intestinal dissociative hard capsules. United State Patent No. 5,283,064.
  • 15
    • 0033582731 scopus 로고    scopus 로고
    • Colon-specific delivery of R68070, a new thromboxane synthase inhibitor, using chitosan capsules: therapeutic effects against 2,4,6-trinitrobenzene sulfonic acid-induced ulcerative colitis in rats
    • Tozaki H., Fujita T., and Odoriba T. Colon-specific delivery of R68070, a new thromboxane synthase inhibitor, using chitosan capsules: therapeutic effects against 2,4,6-trinitrobenzene sulfonic acid-induced ulcerative colitis in rats. Life Sci. 64 (1999) 1155-1162
    • (1999) Life Sci. , vol.64 , pp. 1155-1162
    • Tozaki, H.1    Fujita, T.2    Odoriba, T.3
  • 16
    • 0037133084 scopus 로고    scopus 로고
    • Formulation aspects in the development of osmotically controlled oral drug delivery systems
    • Verma R.K., Krishna D., and Garg M.S. Formulation aspects in the development of osmotically controlled oral drug delivery systems. J. Control. Release 79 (2002) 7-27
    • (2002) J. Control. Release , vol.79 , pp. 7-27
    • Verma, R.K.1    Krishna, D.2    Garg, M.S.3
  • 17
    • 19344372357 scopus 로고    scopus 로고
    • Asymmetric membrane capsules for delivery of poorly water soluble drugs by osmotic effects
    • Wang C.Y., Ho H.O., Lin L.H., Lin Y.K., and Sheu M.T. Asymmetric membrane capsules for delivery of poorly water soluble drugs by osmotic effects. Int. J. Pharm. 297 (2005) 89-97
    • (2005) Int. J. Pharm. , vol.297 , pp. 89-97
    • Wang, C.Y.1    Ho, H.O.2    Lin, L.H.3    Lin, Y.K.4    Sheu, M.T.5
  • 18
    • 0025700057 scopus 로고
    • Encapsulation of mammalian cell with chitosan CMC capsule
    • Yoshioka T., Hirano R., Shioya T., and Kako M. Encapsulation of mammalian cell with chitosan CMC capsule. Biotechnol. Bioeng. 35 (1990) 66-72
    • (1990) Biotechnol. Bioeng. , vol.35 , pp. 66-72
    • Yoshioka, T.1    Hirano, R.2    Shioya, T.3    Kako, M.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.